Clinical Trial Update: Pacritinib for Biochemical Relapse After Definitive Treatment for Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of pacritinib for biochemical relapse after definitive treatment for prostate cancer was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Pacritinib (pacritinib)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2024-12-17